Theo dõi
Gonzalo Carreno-Tarragona
Gonzalo Carreno-Tarragona
MD, PhD, Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain
Email được xác minh tại salud.madrid.org
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ...
Frontiers in Immunology 15, 1488860, 2025
2132025
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
S Nolan, M Vignali, M Klinger, JN Dines, IM Kaplan, E Svejnoha, T Craft, ...
Research square, rs. 3. rs-51964, 2020
1982020
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
A Leivas, A Valeri, L Córdoba, A García-Ortiz, A Ortiz, L Sánchez-Vega, ...
Blood Cancer Journal 11 (8), 146, 2021
1262021
Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies
JM Sanchez‐Pina, M Rodríguez Rodriguez, N Castro Quismondo, ...
European Journal of Haematology 105 (5), 597-607, 2020
1122020
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
NCP Cross, Y Hoade, WJ Tapper, G Carreno-Tarragona, T Fanelli, ...
Leukemia 33 (2), 415-425, 2019
902019
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
T Barbui, AM Vannucchi, A Alvarez-Larran, A Iurlo, A Masciulli, ...
Leukemia 35 (2), 485-493, 2021
892021
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
T Barbui, V De Stefano, A Alvarez-Larran, A Iurlo, A Masciulli, A Carobbio, ...
Blood cancer journal 11 (2), 21, 2021
382021
Optical nanoparticles for cardiovascular imaging
J Hu, DH Ortgies, E Martin Rodriguez, F Rivero, R Aguilar Torres, ...
Advanced Optical Materials 6 (22), 1800626, 2018
362018
Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse
E Onecha, I Rapado, ML Morales, G Carreño-Tarragona, ...
Haematologica 106 (9), 2325, 2020
272020
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
ML Lozano, ME Mingot-Castellano, MM Perera, I Jarque, ...
Scientific Reports 9 (1), 16680, 2019
252019
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to …
A Alvarez‐Larrán, M Garrote, F Ferrer‐Marín, M Pérez‐Encinas, ...
Cancer 128 (13), 2441-2448, 2022
222022
Papain‐treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti‐CD38‐based therapies
G Carreño‐Tarragona, T Cedena, L Montejano, R Alonso, F Miras, ...
Transfusion Medicine 29 (3), 193-196, 2019
222019
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
G Carreño-Tarragona, A Álvarez-Larrán, C Harrison, JC Martínez-Ávila, ...
Blood Advances 7 (9), 1672-1681, 2023
212023
Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes
A Alvarez-Larran, D Martínez, L Arenillas, A Rubio, E Arellano-Rodrigo, ...
Journal of Clinical Pathology 71 (11), 975-980, 2018
192018
Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors
M Granado, N Fernández, L Monge, JC Figueras, G Carreño-Tarragona, ...
PLoS One 8 (2), e54984, 2013
172013
Long-term follow-up of recovered MPN patients with COVID-19
T Barbui, A Iurlo, A Masciulli, A Carobbio, A Ghirardi, G Rossi, C Harrison, ...
Blood Cancer Journal 11 (6), 115, 2021
162021
Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea
A Alvarez-Larrán, A Díaz-González, E Such, E Mora, M Andrade-Campos, ...
Leukemia 35 (2), 623-627, 2021
162021
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
I Cuenca, D Alameda, B Sanchez-Vega, D Gomez-Sanchez, D Alignani, ...
Leukemia 35 (1), 245-249, 2021
162021
Long-term effects of early overnutrition in the heart of male adult rats: role of the renin-angiotensin system
M Granado, N Fernández, L Monge, G Carreño-Tarragona, JC Figueras, ...
Plos one 8 (6), e65172, 2013
162013
Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the …
A Alvarez‐Larrán, A Angona, M Andrade‐Campos, M Soledad Noya, ...
British Journal of Haematology 192 (6), 988-996, 2021
152021
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20